These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7579851)

  • 1. New directions in the treatment of heart failure: some paradoxical observations.
    Merin RG
    J Card Surg; 1995 Jul; 10(4 Suppl):509-13. PubMed ID: 7579851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Masson S; Masseroli M; Fiordaliso F; Calvillo L; D'Aquila S; Bernasconi R; Garrido G; Torri M; Razzetti R; Bongrani S; Latini R
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and newer approaches in the drug treatment of congestive heart failure.
    van Zwieten PA
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):693-702. PubMed ID: 9110112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
    Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
    J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of inhibitors of the angiotensin-converting enzyme and the beta-adrenoblocker metoprolol combined in treatment of chronic cardiac insufficiency].
    Voronkov LG; Serdiuk TE; Riabenko DV
    Lik Sprava; 2000; (7-8):77-80. PubMed ID: 16786657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for heart failure: good news and bad.
    Assomull R; Elliott PM
    Hosp Med; 2005 Feb; 66(2):102-5. PubMed ID: 15739707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15 years of heart-failure trials: what have we learned?
    Massie BM
    Lancet; 1998 Aug; 352 Suppl 1():SI29-33. PubMed ID: 9736477
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
    Ruffolo RR; Kopia GA
    Am J Med; 1986 Feb; 80(2B):67-72. PubMed ID: 2868661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
    Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
    J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 1993 May; 35(896):40-2. PubMed ID: 8097552
    [No Abstract]   [Full Text] [Related]  

  • 13. Protocol Underemphasizes beta-blockers.
    Chase SL
    J Am Pharm Assoc (Wash); 2001; 41(6):793-4. PubMed ID: 11765101
    [No Abstract]   [Full Text] [Related]  

  • 14. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
    [No Abstract]   [Full Text] [Related]  

  • 15. Present and future pharmacotherapy for heart failure.
    Doggrell SA; Brown L
    Expert Opin Pharmacother; 2002 Jul; 3(7):915-30. PubMed ID: 12083991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention and treatment of congestive heart failure in diabetic patients].
    Anguita Sánchez M
    Rev Esp Cardiol; 2002 Oct; 55(10):1083-7. PubMed ID: 12383394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
    Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
    Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out-patient management of chronic heart failure.
    Terrovitis JV; Anastasiou-Nana MI; Nanas JN
    Expert Opin Pharmacother; 2005 Sep; 6(11):1857-81. PubMed ID: 16144507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.